化学&生物药
在化学&生物药领域，最新融资动态显示：Neurotech Pharmaceuticals Inc完成收并购融资，投资方为Alcon。更多详细融资信息，可通过专题列表查阅。
2026-10-20
临床阶段生物制药商
医药研发/制造
化学&生物药
National Institute of General Medical Sciences;
2026-10-19
创新抗体开发商
医药研发/制造
化学&生物药
Vestal Point Capital;
Vestal Point Capital;
TCGX;
TCGX;
First Light Asset Management;
Affinity Asset Advisors;
2026-10-19
癌症免疫疗法开发商
医药研发/制造
化学&生物药
Revelation Partners;
Revelation Partners;
M Ventures;
M Ventures;
Versant Ventures;
Panakes Partners;
Indaco Venture Partners;
EQT Partners;
Angelini Ventures;
Andera Partners;
5AM Ventures;
NEVA SGR;
2026-10-19
基因技术研发商
医药研发/制造
化学&生物药
California Institute for Regenerative Medicine;
2026-10-16
微生物组疗法开发商
医药研发/制造
化学&生物药
British Business Bank;
British Business Bank;
Seventure Partners;
Seventure Partners;
Flerie Invest;
IP Group Plc;
腾讯投资;
2026-10-16
基因药物开发商
医药研发/制造
化学&生物药
RA Capital;
RA Capital;
GV;
GV;
4BIO Capital;
Pivotal bioVenture Partners;
UPMC Enterprise;
Deep Track Capital;